FINELINE II Sterox and Sterox EZ pace/sense leads
Boston Scientific · Decision date Mar 6, 2026
What did the FDA approve?
FDA records P960004/S113 as a supplement to PMA P960004, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Mar 6, 2026.
FDA approval order statement
approval for the related transfer of the downstream final packaging process from the Boston Scientific Puerto Rico Dorado site to Boston Scientific Quincy, Massachusetts facility to enable regionally co-located operations for the CRM leads.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 6, 2026
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P960004/S113
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- NVN
- Decision code
- APPR
- Decision date
- Mar 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Applicant
- Boston Scientific
- Product code
- NVN
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P960004/S107 · Related supplement
Stylets Models 6053, 6054, 6055
P960004/S108 · Related supplement
THINLINE ENDOCARDIAL PACING LEADS
P960004/S106 · Related supplement
FINELINE II EZ Sterox
P960004/S110 · Related supplement
ACC STY ITM STR .016 52CM; ACC STY ITM STR .016 45CM; ACC STY ITM STR .014 58CM; ACC STY ITM STR .014 52CM; ACC STY ITM
P960004/S109 · Related supplement
FINELINE II Leads
P960004/S113 received
Application receipt date recorded by FDA.
P960004/S112 · Related supplement
FINELINE II Sterox and Sterox EZ pace/sense leads
P960004/S113 · FDA decision
Normal 180 Day Track No User Fee
P960004/S114 · Related supplement
Straight Lead Stylets Limber Models 6033, 6034; Straight Lead Stylets Firm Models 6036, 6037; J Shaped Lead Stylets Limb
P960004/S115 · Related supplement
Stylet (Models 6033, 6034, 6036, 6037, 6039, 6040, 6042, 6043, 6053, 6054, 6055, 6058, 6059, 6062, 6063, 6064, 6065, 606
P960004/S116 · Related supplement
ThinLine/FineLine Family of Endocardial Pacing Leads Models: 4456, 4457, 4469, 4470, 4471, 4479, 4480
Timeline entries are records held by MedtechLedger for P960004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Stylets Models 6053, 6054, 6055P960004/S107 | Boston Scientific | PMA supplement | Jul 28, 2025 | FDA |
THINLINE ENDOCARDIAL PACING LEADSP960004/S108 | Boston Scientific | PMA supplement | Aug 19, 2025 | FDA |
FINELINE II EZ SteroxP960004/S106 | Boston Scientific | PMA supplement | Aug 22, 2025 | FDA |
| Boston Scientific | PMA supplement | Sep 16, 2025 | FDA | |
FINELINE II LeadsP960004/S109 | Boston Scientific | PMA supplement | Oct 24, 2025 | FDA |
| Boston Scientific | PMA supplement | Feb 20, 2026 | FDA | |
| Boston Scientific | PMA supplement | Apr 10, 2026 | FDA | |
| Boston Scientific | PMA supplement | May 15, 2026 | FDA | |
| Boston Scientific | PMA supplement | Jun 3, 2026 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC SELECTSECURE LEAD MODEL 3830P030036/S162 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 16, 2026 | FDA |
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
SelectSecure Lead 3830P030036/S161 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Aug 5, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA | |
IsoFlex LeadsP960030/S085 | ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P960004/S113
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





